Merck to stop making APIs at Pennsylvania site and cut 300 jobs by 2024
In 2024, Merck will discontinue its manufacturing of active pharmaceutical ingredients. And with that move, it will no longer need its Cherokee manufacturing site in Danville, PA.
The site will close when API production stops, the company said to Endpoints News in a statement emailed Thursday. The news was first reported by local newspaper The Daily Item Wednesday. County commissioner Sam Schiccatano told the paper that the county was informed of the closure that afternoon. The plant is one of the area’s largest employers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.